Abstract
Bronchopulmonary dysplasia (BPD) is a chronic lung disease that represents the principal cause of morbidity in extremely preterm infants. There is no therapy for BPD.
'BPD is defined as the requirement for respiratory support for at least 28 days. BPD is characterised by lung inflammation. Prevention or attenuation of inflammation offers a realistic therapeutic for BPD.
We utilised low-dose postnatal steroids and human amnion epithelial cells (hAECs) in separate studies to prevent inflammation and BPD-like pathology in preterm lambs. We show low-dose postnatal steroids reduce lung inflammation, while hAECs augment lung inflammation. Neither therapy reduced ventilator requirements in preterm lambs.
'BPD is defined as the requirement for respiratory support for at least 28 days. BPD is characterised by lung inflammation. Prevention or attenuation of inflammation offers a realistic therapeutic for BPD.
We utilised low-dose postnatal steroids and human amnion epithelial cells (hAECs) in separate studies to prevent inflammation and BPD-like pathology in preterm lambs. We show low-dose postnatal steroids reduce lung inflammation, while hAECs augment lung inflammation. Neither therapy reduced ventilator requirements in preterm lambs.
Original language | English |
---|---|
Qualification | Doctor of Philosophy |
Awarding Institution |
|
Supervisors/Advisors |
|
Thesis sponsors | |
Award date | 15 Feb 2019 |
DOIs | |
Publication status | Unpublished - 2019 |